$0.9095
-0.10-9.95%
Last update: Nov 5, 12:04 PM
Marker Therapeutics Inc
MRKRNASDAQ
The average analyst price target for Marker Therapeutics is $12.38, 1261.2% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $8 to $19. The latest change came on Dec 8, 2025, when HC Wainwright & Co. initiated coverage of Marker Therapeutics with a Buy rating and a $10 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
